Skip to main content

Publications


Click on the icon to view the publication.

 

  

Click on the icon to view the abstract.

 

 

 

 

 

 Disclaimer: Please note that you may download and print these papers for personal use only. No part of these papers may be distributed or copied for any commercial purpose, even where there is no direct commercial gain, without receiving the explicit written permission of the author or the publisher. You must not incorporate this material, or any part of it, in any work or publication, whether in paper copy or electronic or any other form without the permission of the author or the publsiher.

 


2017



2016

  • Cappuccio FP, Buchanan LA, Ji C, Siani A, Miller MA. Systematic review and meta-analysis of randomised controlled trials on the effects of potassium supplements on serum potassium and creatinine. BMJ Open. 2016 Aug 26;6(8):e011716. doi: 10.1136/bmjopen-2016-011716.
  • Cappuccio FP, Miller MA. Cardiovascular disease and hypertension in sub-Saharan Africa: burden, risk and interventions.Intern Emerg Med. 2016 Apr;11(3):299-305. doi: 10.1007/s11739-016-1423-9. Epub 2016 Mar 21. Review.


2015

  • Tang NK, Lereya ST, Boulton H, Miller MA, Wolke D, Cappuccio FP. Nonpharmacological Treatments of Insomnia for Long-Term Painful Conditions: A Systematic Review and Meta-analysis of Patient-Reported Outcomes in Randomized Controlled Trials. Sleep. 2015 Nov 1;38(11):1751-64. doi: 10.5665/sleep.5158. Review
  • Miller MA. The Role of Sleep and Sleep Disorders in the Development, Diagnosis, and Management of Neurocognitive Disorders. Front Neurol. 2015 Oct 23;6:224. doi: 10.3389/fneur.2015.00224. eCollection 2015.


2014

  • Miller MA, Wright H, Hough J, Cappuccio FP (2014) 'Sleep and Cognition' in "Sleep and its Disorders Affect Society",, 3 - 28, Editors: Chris Idzikowski,, Medicine: Intech
  • Miller MA, Wright H, Ji C, Cappuccio FP. Cross-Sectional Study of Sleep Quantity and Quality and Amnestic and Non-Amnestic Cognitive Function in an Ageing Population: The English Longitudinal Study of Ageing (ELSA). PLOS ONE. Published: June 26, 2014DOI: 10.1371/journal.pone.0100991
  • Miller MA, Smith G, O’Keefe A, Cappuccio FP. Sleep and Obesity. In. Handbook of Obesity, Third Edition, Vol. 1, Epidemiology, Etiology, and Physiopathology. Ed Bray and Bouchard (In Press Feb 2014).


2013

  • Miller MA. Sleep, Nature’s soft nurse. Is sloth unavoidable? The Biochemist. 2013 Dec; 35(6): 16-22
  • Ferrie J, Kivimäki M, Akbaraly TN, Singh-Manoux, A, Miller MA, Gimeno D, Kumari M, Davey Smith G, Shipley MJ. Associations between change in sleep duration and inflammation: Findings on C-reactive protein and interleukin 6 in the Whitehall II study.

    Am J Epidemiol. 2013 Sep 15;178(6):956-61. doi: 10.1093/aje/kwt072. Epub 2013 Jun 25.

  • Miller MA & Cappuccio FC. Biomarkers of cardiovascular risk in sleep deprived people. J Human Hytpertens 2013; 1-6
  • Ji C, Miller MA, Venezia A, Strazzullo P, Cappuccio FP. Comparison of spot vs 24h urine samples for population estimates of salt intake: Validation study in two independent samples of adults in Britain and Italy. Nutr Metab Cardiovasc Dis. 2013 (on line xx 1-8).
  • Cappucio FP & Miller MA. Sleep and mortality: cause, consequence or symptom? Sleep Med. 2013 May 16. doi:pii: S1389-9457(13)00132-9. 10.1016/j.sleep.2013.04.001. [Epub ahead of print].
  • Miller MA, Cappuccio FP. Quantity and quality of sleep and the risk of developing type-2 diabetes. In. Handbook of Nutrition Diet and Sleep. Ed Preedy. Wageningen Academic Publishers; 2013.

 

2012

  • Miller MA and Cappuccio FP. Sleep, hypertension and diabetes. In. Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome. Eds Debasis Bagchi and Sreejayan Nair. Elsevier. (March 2012).
  • Miller MA, Ahuja M and Cappuccio FP. Sleep deprivation, sleep disturbed breathing and sleep disorders in pregnancy. In. Sleep Disorders. Ed Chris Idzikowski In Tech. April 2012.
  • Cappuccio FP & Miller MA (Editorial). A New Challenge to Widely Held Views on The Role of Sleep. Annals of internal Medicine 2012.
  • Arnaud J, de Lorgeril AJ, M, Akbaraly T, Salen P, Arnout J, Cappuccio FP, van Dongen MC, Donati MB, Krogh V, Siani A, Iacoviello L; European Collaborative Group of the IMMIDIET Project. Gender differences in copper, zinc and selenium status in diabetic-free metabolic syndrome European population - the IMMIDIET study. Nutr Metab Cardiovasc Dis. 2012 Jun;22(6):517-24. Epub 2010 Dec 28.
  • Harte A, da Silva NF, Miller MA, Cappuccio FP, Kelly MA, O’Hare JP, Barnett AH, Al-Daghri N, Sabico S, Kuma S, McTernan PG. Telomere Length Attrition, a Marker of Biological Senescence, Is Inversely Correlated With Triglycerides And Cholesterol In South Asian Males with Type 2 Diabetes Mellitus. Exp Diabetes Res. 2012;2012:895185. Epub 2012 Mar 1.
  • Miller MA and Cappuccio FP. Chapter 13: Sleep and Obesity. In. Obesity: Epidemiology, Pathophysiology and Prevention. Ed Debasis Bagchi. CRC Press/Taylor & Francis; 2012 .

 

2011

  • C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC), Wensley F, Gao P, Burgess S, Kaptoge S, Di Angelantonio E, Shah T, Engert JC, Clarke R, Davey-Smith G, Nordestgaard BG, Saleheen D, Samani NJ, Sandhu M, Anand S, Pepys MB, Smeeth L, Whittaker J, Casas JP, Thompson SG, Hingorani AD, Danesh J. (MA Miller as one of the 157 collaborators). Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ. 2011 Feb 15;342:d548. doi: 10.1136/bmj.

  • Cappuccio FP*, Cooper D, D’Elia L, Strazzullo P, Miller MA*. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. European Heart Journal 2011;32(12):1484-92.

  •  Miller MA. Association of inflammatory markers with cardiovascular risk and sleepiness. J Clin Sleep Med. 2011 Oct 15;7(5 Suppl):S31-3

  • Cappuccio FP & Miller MA. Are short bad sleep nights a hindrance to a healthy heart? Commentary on Hoevenaar-Blom et al. Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: The MORGEN Study. SLEEP 2011 Nov 1;34(11):1457-8).

  • Galletti F, D'Elia L, De Palma D, Russo O, Barba G, Siani A, Miller MA, Cappuccio FP, Rossi G, Zampa G, Strazzullo P. Hyperleptinemia is associated with hypertension, systemic inflammation and insulin resistance in overweight but not in normal weight men. Nutr Metab Cardiovasc Dis. 2011 Sep 13. [Epub ahead of print].

  • Cappuccio FP, Miller MA. Is prolonged lack of sleep associated with obesity? BMJ. 2011 May 26;342:d3306. doi: 10.1136/bmj.d3306. No abstract available.

  • Miller MA and Cappuccio FP. Sleep and Obesity. In. Obesity: Epidemiology, Pathophysiology and Prevention. Ed Debasis Bagchi. CRC Press/Taylor & Francis. (In press 2011).


 2010

  • Miller MA, Kandala N-B, Marmot MG, Cappuccio FP. Relationships between sleep duration and Von Willebrand Factor, Fibrinogen and Factor VII: Whitehall II study. ATVB 2010 Oct;30(10):2032-8. Epub 2010 Jul 22. http://atvb.ahajournals.org/cgi/reprint/ATVBAHA.110.206987?ijkey=JbQnuHRTUbqyySb&keytype=ref

  • Shah T, Newcombe P, Smeeth L, Addo J, Casas JP, Whittaker J, Miller MA, Tinworth L, Jeffery S, Strazzullo P, Cappuccio FP, Hingorani ADAncestry as a determinant of mean population C-reactive protein values: implications for cardiovascular risk prediction. Circulation Genetics Circ Cardiovasc Genet. 2010 Oct 1;3(5):436-44  

  • Cappuccio FP, D’Elia L, Strazzullo P Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2010 Feb;33(2):414-20.

  • Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. Sleep duration and all cause-mortality: a systematic review and meta-analysis of prospective studies. Sleep 2010 May 1;33(5):585-92.

  • Miller MA. Chapter. Adhesion Molecules in Obesity and Metabolic Syndrome. In Modern Insights into Disease from Molecules to Man:  Adhesion Molecules, 2010 June: V R Preedy (editor), London.

  • Stranges S, Dorn JM, Cappuccio FP, Donahue RP, Hovey KM, Kandala N-B, Miller MA, Trevisan M. A population-based Study of Reduced Sleep Duration and Hypertension: The Strongest Association may be in Pre-Menopausal Women 2009; J Hypertension. 28(5): 896-902.  

  • Cappuccio FP, Miller MA & Lockley SW. Sleep Epidemiology: from aetiology to public health. Oxford University Press, 2010; September 23 2010
  • Cappuccio FP, Miller MA & Lockley SW. Chapter 1: Sleep, Health and Society: the contribution of epidemiology. In: Sleep Epidemiology: from aetiology to public health. FP Cappuccio, MA Miller, SW Lockley eds. Oxford University Press, 2010; September 23 2010
  • Cappuccio FP & Miller MA. Chapter 5: The epidemiology of sleep and cardiovascular risk and disease. In: Sleep Epidemiology: from aetiology to public health. FP Cappuccio, MA Miller, SW Lockley eds. Oxford University Press, 2010; September 23 2010
  • Miller MA & Cappuccio FP. Chapter 11: Sleep, inflammation and disease. In: Sleep Epidemiology: from aetiology to public health. FP Cappuccio, MA Miller, SW Lockley eds. Oxford University Press, 2010; September 23 2010
  • Miller MA. Chapter 12 Genetics & Sleep. In: Sleep Epidemiology: from aetiology to public health. FP Cappuccio, MA Miller, SW Lockley eds. Oxford University Press, 2010; September 23 2010
  • Cappuccio FP & Miller MA. Chapter 18: European Working Time Directive and medical errors. In: Sleep Epidemiology: from aetiology to public health. FP Cappuccio, MA Miller, SW Lockley eds. Oxford University Press, 2010; September 23 2010

 

2009

  • Latella MC, Di Castelnuovo A, de Lorgeril M, Arnout J, Cappuccio FP, Krogh V, Siani A, van Dongen M, Donati MB, de Gaetano G, Iacoviello L; European Collaborative Group of the IMMIDIET Project. Genetic variation of alcohol dehydrogenase type 1C (ADH1C), alcohol consumption, and metabolic cardiovascular risk factors: results from the IMMIDIET study. Atherosclerosis. 2009 Nov;207(1):284-90. Epub 2009 Apr 24.
  • Rice N, Baninelli, Cori AM, Ferrucci L, Guralnik JM, Kumari M, Miller MA, Murray A, Frayling TM, Melzer D. The paroxonase (PON1) Q192R polymorphism is not associated with poor health status or depression in the ELSA or InCHIANTI studies. International Journal of Epidemiology 2009; 38(5):1374-9.
  • Miller MA & Cappuccio FP. Endotoxin and metabolic syndrome. Atherosclerosis 2009: Letter (In Press)
  • Miller MA; Kandala NB; Kivimaki M; Kumari M; Brunner EJ; Lowe GDO; Marmot MG; Cappuccio FP. Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II study. SLEEP 2009;32(7):857-864
  • di Giuseppe R, de Lorgeril M, Salen P, Laporte F, Di Castelnuovo A, Krogh V, Siani A, Arnout J, Cappuccio FP, van Dongen M, Donati MB, de Gaetano G, Iacoviello L; European Collaborative Group of the IMMIDIET Project. Alcohol consumption and n-3 polyunsaturated fatty acids in healthy men and women from 3 European populations. Am J Clin Nutr. 2009 Jan;89(1):354-62. Epub 2008 Dec 3.

  • Tabak AG, Brunner EJ, Miller MA, Karanam S, McTernan PG, Cappuccio FP, Witte DR. Low serum adiponectin predicts 10-year risk of type 2 diabetes and HbA1c independently of obesity, lipids and inflammation –Whitehall II study. Horm Metab Res.2009; 41(8)626-9.Epub 2009 Apr 15.

  • Miller MA, Strazzullo P, Karanam S, Cappuccio FP. Ethnic variation in circulating antibodies levels to oxidised low-density lipoprotein. Atherosclerosis. 2009 Mar;203(1):126-36. Epub 2008 Jun 5. http://dx.doi.org/10.1016/j.atherosclerosis.2008.05.053.

  • Miller MA. McTernan PG, Harte AL da Silva NF, Strazzullo P, Alberti GMM, Kumar S, Cappuccio FP. Circulating endotoxin levels: a novel marker of cardiovascular and metabolic risk in a British multi-ethnic population. Atherosclerosis 2009; 203:494-502.
  • Sanderson SC, Kumari M, Brunner E, Miller MA, Rumley A, Lowe G, Marmot M, Humphries SE. Association between IL6 gene variants -174G>C and -572G>C and serum IL-6 levels: interactions with social position in the Whitehall II cohort. Atherosclerosis. 2009 Jun;204(2):459-64. Epub 2008 Sep 27.

     

2008

  • Costanzo S, Di Castelnuovo A, Zito F, Krogh V, Siani A, Arnout J, Cappuccio FP, Miller MA, van Dongen M, de Lorgeril M, de Gaetano G, Benedetta Donati M, Iacoviello L, on behalf of the European Collaborative Group of the IMMIDIET Project. Prevalence, awareness, treatment and control of hypertension in healthy unrelated male-female pairs of European regions: the dietary profile in European communities with different risk of myocardial infarction- the impact of migration as a model of gene-environment interaction project. J Hypertens 2008 26:1-10
  • Brunner EJ, Kivimäki M, Witte DR, Lawlor DA, Smith GD, Cooper JA, Miller MA, Lowe GDO, Rumley A, Casas JP, Shah T, Humphries SE, Hingorani AD, Marmot MG, Timpson NJ, Kumari M. Inflammation, Insulin Resistance, and Diabetes - Mendelian Randomization Using CRP Haplotypes Points Upstream. PLoS Medicine; 5(8) e155.
  • Kivimäki M, Lawlor DA, Smith GD, Kumari M;Donald A, Britton A, Cases JP, Shah T, Brunner E, Timpson NJ, Halcox JPJ, Miller MA, Humphries SE, Deanfield J, Marmot MG, Hingorani AD. Does High C-reactive Protein Concentration Increase Atherosclerosis? The Whitehall II Study. PLoS ONE 2008; 3(9) e3013.
  • Cappuccio FP, Taggart FM, Knadala N-B, Currie A, Peile E, Stranges S, Miller MA. Short sleep duration and obesity. A systematic review and meta-analysis of population-based observational studies in children and adults across the world. Sleep 2008; 31(5): 619-26
  • Stranges S, Cappuccio FP, Kandala NB, Miller MA, Taggart FM, Kumari M, Ferrie JE, Shipley MJ, Brunner EJ, Marmot MG. Cross-sectional versus Prospective Associations of Sleep Duration with Changes in Relative Weight and Body Fat Distribution: The Whitehall II Study. Am J Epidemiol 2008; 167: 321-9
  • Russo P, Siani A, Miller MA, Karanam S, Esposito T, Gianfrancesco F, Barba G, Lauria F, Strazzullo P, Cappuccio FP. Genetic variants of Y chromosome are associated with a protective lipid profile in black men. Arterioscl Thromb Vasc Biol 2008; 28(8):1569-74. Epub 2008 May 29. in press.
  • Saverio Stranges, Joan M Dorn, Martin J Shipley, Ngianga-Bakwin Kandala, Maurizio Trevisan, Michelle A Miller, Richard P Donahue, Kathleen M Hovey, Jane E Ferrie, Michael G Marmot, Francesco P Cappuccio. Correlates of Short and Long Sleep Duration: Cross-cultural Comparison between UK and US. The Whitehall II Study and the Western New York Health Study. Am J Epidemiol 2008;168:1353-1364.


2007

  • Ferrie JE, Shipley MJ, Brunner E, Cappuccio FP, Miller MA, Kumari M, Marmot MG. Sleep duration and change in sleep duration; associations with mortality in the Whitehall II cohort. Sleep 2007; 30(12) 1659-1666 (PDF Document) 
  • Cappuccio FP, Stranges S, Kandala N-B, Miller MA, Taggart FM, Kumari M, Ferrie JE, Shipley MJ, Brunner EJ, Marmot MG. Gender-specific associations of short sleep duration with prevalent and incident hypertension: the Whitehall II Study. Hypertension; 2007:2007 Oct;50(4):693-700. Epub 2007 Sep 4. Erratum in: Hypertension. 2007 Nov;50(5):e170.
  • Miller M A, Cappuccio F P. Invited Review: Inflammation, sleep, obesity and cardiovascular disease. Curr Vasc Pharmacol 2007;5(2): 93-102.
  • Miller M A, Cappuccio F P. Invited Review: Ethnicity and inflammatory pathways- implications for vascular disease, vascular risk and therapeutic intervention. Current Medicinal Chemistry 2007;14(13):1409-1425.(PDF Document) 


2006

  • Humphries SE, Gable D, Cooper JA, Ireland H, Stephens J, Li KW, Palmen J, Miller MA, Cappuccio FP, Elkeles R, Godsland I, Miller GJ, Talmud PJ. Common variants in the TCF7L2 gene and predisposition to Type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women. J Mol Med 2006;84:1-10
  • Cappuccio FP, Miller MA. Energy cannot be created nor destroyed. Nutr Metab Cardiovasc Dis. 2006 Oct;16(7):e11; author reply e13-4. Epub 2006 Aug 28. No abstract available.
  • Miller MA, Cappuccio FP. Cellular adhesion molecules and their relationship with measures of obesity and metabolic syndrome in a multi-ethnic population Int J Obes (lond). 2006 Aug;30(8):1176-82.Epub 2006 Mar 7.


2005

  • Miller MA, Kerry SM, Dong YB, Sagnella GA, Cook DG, Cappuccio FP. Circulating soluble E-selectin levels and the Ser128Arg polymorphism in individuals from different ethnic groups. NMCD. 2005; 15:65-70.


2004

  • Barbato A, Russo P, Siani A, Folkerd EJ, Miller MA, Venezia A, Grimaldi C, Strazzullo P, Cappuccio FP. Aldosterone synthase gene (CYP11B2) C-344T polymorphism, blood pressure and plasma aldosterone levels in a multiethnic population. J Hypertension 2004; 22:1895-1901.
  • Miller MA, Kerry SM, Dong Y, Strazzullo P, Cappuccio FP. Association between the Thr715Pro P-Selectin gene polymorphism and soluble P-Selectin levels in different ethnic groups. Thromb Haemost. 2004; 92(5):1060-5.
  • Miller MA, Strazzullo P, Cook DG, Cappuccio FP. Cellular adhesion molecules and blood pressure: interaction with gender in a multiethnic population. J Hypertens. 2004; 22:705-711.
  • Zhu H, Sagnella GA, Dong Y, Miller MA, Onipinla A, Markandu ND, MacGregor GA. Molecular variants of the sodium/hydrogen exchanger type 3 gene and essential hypertension. J Hypertens. 2004 Jul;22(7):1269-75.


2003

  • Miller MA, Sagnella GA, Kerry SM, Strazzullo P, Cook DG, Cappuccio FP. Ethnic differences in circulating soluble adhesion molecules. The Wandsworth Heart & Stroke Study. Clin Sci (Lond). 2003; 104(6):591-8.
  • Zhu H, Sagnella G, Dong Y, Miller MA, Onipinla A, Markandu ND, MacGregor GA. Contrasting associations between Aldosterone synthase gene polymorphisms and essential hypertension in blacks and in whites. J Hypertens. 2003 Jan;21(1):87-95.


2002

  • Miller MA, Cappuccio FP. Reducing cholesterol and atherosclerosis: the importance of cellular adhesion molecules? QJM. 2002 Oct;95(10):707-8. (Letter).
  • Cappuccio FP, Miller MA. Soluble adhesion molecules and coronary heart disease. Lancet 2002; 359:525. (Letter).


2001

  • Miller MA, Sagnella GA, Markandu ND, MacGregor GA. Ethnic differences in membrane fluidity and the association with serum triacylglycerols. Clinical Science 2001; 100:653-658.
  • Khong TK, Sagnella GA, Markandu ND, Miller MA, Missouris CG, MacGregor GA. Platelet sodium-hydrogen exchanger activity and left ventricular mass index. J Human Hypertens 2001; 8:523-7.
  • Khong TK, Intyre DJO, Sagnella GA, Markandu ND, Miller MA, Griffiths JR, MacGregor GA. In vivo intracellular pH at rest and during exercise in patients with essential hypertension. J Hypertens 2001; 9:1595-600.


2000

  • Miller MA, Khong TK, Sagnella GA, Markandu ND, MacGregor GA. Urinary acid-base excretion in normotensives and hypertensives of African Origin. J Human Hypertens 2000; 14:455-459.


1999

  • Baker EH, Portal AJ, McElvaney TA, Blackwood AM, Miller MA, Markandu ND, MacGregor GA. Epithelial sodium channel activity is not increased in hypertension in whites. Hypertens 1999; 33:1031-5
  • Sagnella GA, Miller MA, Khong TK, MacGregor GA. Platelet sodium/hydrogen exchanger activity in normotensives and hypertensives. Clin Chem Acta 1999; 283:105-18.


1998

  • Singer DRJ, Markandu ND, Buckley MG, Miller MA, Sagnella GA, MacGregor GA. Contrasting endocrine response to acute oral compared with intravenous sodium loading in normal humans. Am. J. Physiol 1998; 274 (43): F111-F119.


1997

  • Miller MA, Sagnella GA, MacGregor GA. Comparison of an extraction method for the measurement of plasma aldosterone with a non extracted kit method. Clin Chem 1997; 43(10): 1995-1997.


1996

  • Barley J, Blackwood A, Miller M, Markandu ND, Carter ND, Jeffery S, Cappuccio FP, MacGregor GA, Sagnella GA. Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Human Hypertens 1996; 10: 31-35.
  • Miller MA, Sagnella GA, Blackwood AM, Markandu ND, MacGregor GA. Determinants of membrane microviscosity in human erythrocytes: association with gender, blood pressure and serum lipids. J Human Hypertens 1996; 10: 419-420.
  • J Inoue, Cappuccio FP, Sagnella GA, Markandu ND, Folkerd EJ, Sampson B, Miller MA, Blackwood AM, MacGregor GA. Glucose load and renal sodium handling in mild essential hypertension on different sodium intakes. J Human Hypertens 1996; 10: 523-529.


1995

  • Sagnella GA, Markandu ND, Buckley MG, Miller MA, Blackwood A, Singer DRJ, MacGregor GA. Hormonal and renal response to neutral endopeptidase inhibition in normal humans on a low and on a high sodium intake. Eur J Clin Invest 1995; 25: 165-170.
  • Singer DRJ, Markandu ND, Cappuccio FP, Miller MA, Sagnella GA, MacGregor GA. Reduction of salt intake during converting enzyme inhibitor treatment compared with addition of a thiazide. Hypertens 1995; 25: 1042-1044.


1994

  • Strazzullo P, Cappuccio FP, Miller MA, Buckley MG, Sagnella GA, Trevisan, Pagano E, MacGregor GA with the technical assistance of Roberto Iacone. Erythrocyte sodium-lithium contertransport: relationship with plasma renin activity, aldosterone and atrial natriuretic peptide in a population study. J Human Hypertens 1994; 8: 199-204.
  • Singer DRJ, Markandu ND, Morton JJ, Miller MA, Sagnella GA, MacGregor GA. Angiotensin II suppression is a major factor permitting excretion of an acute sodium load in humans. Am J Physiol 1994; 266: F89-F93.
  • Singer DRJ, Markandu ND, Buckley MG, Miller MA, Sagnella GA, Lachno DR, Cappuccio FP, Maurday A, Yacoub MH, MacGregor GA. Blood pressure and endocrine responses to changes in dietary sodium intake in cardiac transplant recipients, implications for the control of sodium balance. Circulation 1994; 89: 1153-1159.
  • Blackwood AM, Inoue J, Sagnella GA, Miller MA, Markandu ND, MacGregor GA. Are the changes in urinary kallikrein excretion upon altering sodium intake an index of salt sensitivity? J Human Hypertens 1994; 8: 619-621.
  • Miller MA, Sagnella GA, Markandu ND, MacGregor GA. Comparisons of calcium-magnesium ATPase activity and membrane fluidity in patients with essential hypertension and in normotensive controls. J Hypertens 1994; 12: 929-938.


1993

  • Buckley MG, Markandu ND, Miller MA, Sagnella GA, MacGregor GA. Plasma concentrations and comparisons of brain natriuretic peptide in normal subjects and in patients with essential hypertension. J Human Hypertens 1993; 7: 245-250.
  • Miller MA, Sagnella GA, Markandu ND, MacGregor GA. Determinants of platelet intracellular free calcium in hypertension and effects of stimulation by arginine vasopressin. Am J Hypertens 1993; 6: 209-216.


1991

  • Singer DRJ, Shirley DG, Markandu ND, Miller MA, Buckley MG, Sugden AL, MacGregor GA. How important are suppression of aldosterone and stimulation of atrial natriuretic peptide secretion in the natriuretic response to acute sodium load in man? Clin Sci 1991;80: 293-299.
  • Sagnella GA, Markandu ND, Buckley MG, Miller MA, Singer DRJ, Cappuccio FP, MacGregor GA. Atrial natriuretic peptides in essential hypertension: basal plasma levels and relationship to sodium balance. Can J Physiol & Pharmacol 1991; 69: 1592-1600.
  • Cappuccio FP, Strazzullo P, Giorgione N, Iacone R, Farinaro E, Buckley MG, Miller MA, Sagnella GA, MacGregor GA, Mancini M. Renal tubular sodium handling and plasma atrial natriuretic peptides, renin activity and aldosterone in untreated man under normal living conditions. Eur J Clin Invest 1991; 21: 40-46.
  • Cappuccio FP, Markandu ND, Singer DRJ, Buckley MG, Miller MA, Sagnella GA, MacGregor GA. A double blind crossover study of the effect of concomitant diuretic therapy in hypertensive patients treated with amlodipine. Am J Hypertens 1991; 4: 297-302.
  • Cappuccio FP, Markandu ND, Sagnella GA, Singer DRJ, Buckley MG, Miller MA, MacGregor GA. Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension. J Human Hypertens 1991; 5: 115-119.
  • Shirley DG, Singer DRJ, Sagnella GA, Buckley MG, Miller MA, MacGregor GA. Effect of a single dose of lithium carbonate on sodium and potassium excretion in man. Clin Sci 1991; 81: 59-63.
  • Sagnella GA, Markandu ND, Singer DRJ, Buckley MG, Miller MA, MacGregor GA. Humoral effects of perindopril in essential hypertension. Eur J Clin Pharmacol 1991; 41: 625-626.
  • Singer DRJ, Markandu ND, Buckley MG, Miller MA, Sagnella GA, MacGregor GA. Dietary sodium and inhibition of Neutral Endopeptidase 24.11 in essential hypertension. Hypertens 1991; 18: 798-804.
  • Cappuccio FP, Markandu ND, Sagnella GA, Singer DRJ, Miller MA, Buckley MG, MacGregor GA. Acute and sustained changes in sodium balance during nifedipine treatment in essential hypertension. Am J Medicine 1991; 91(3): 233-238.
  • Singer DRJ, Markandu ND, Sugden AL, Miller MA, Sagnella GA, MacGregor GA. Sodium restriction in hypertensive patients treated with a converting enzyme inhibitor and a thiazide. Hypertens 1991; 17: 798-803.


1990

  • Hla-Yee-Yee, Shirley DG, Singer DRJ, Markandu ND, Buckley MG, Sugden AL, Miller MA, MacGregor GA. Lack of effect of dietary potassium on renal lithium clearance in man. Scand J Clin Lab Invest 1990; 50: 379-384.
  • Miller MA, Sagnella GA, Markandu ND, MacGregor GA. Radioimmunoassay for plasma neuropeptide-Y in physiological and pathophysiological states and response to sympathetic activation. Clinica Chimica Acta 1990; 192: 47-54.
  • Sagnella GA, Markandu ND, Buckley MG, Miller MA, Singer DRJ, MacGregor GA. Plasma atrial natriuretic peptide, aldosterone, and plasma renin activity responses to gradual changes in dietary sodium intake. A J Hypertens 1990; 3: 863-865.


1989

  • Sagnella GA, Markandu ND, Buckley MG, Miller MA, Singer DRJ, MacGregor GA. Hormonal response to gradual changes in dietary sodium intake in man. Am J Physiol 1989; 256: R1171-R1175.
  • Spencer SJW, Sagnella GA, Markandu ND, Miller MA, Buckley MG, MacGregor GA. Plasma ANP in chronic renal failure and effects of changes in dietary sodium intake. American Society Hypertension symposium series: Progress in atrial peptide research Vol III. ed BM Brenner and JH Laragh, Raven Press Ltd. New York 1989; Vol 3: 131-139.
  • Singer DRJ, Markandu ND, Buckley MG, Miller MA, Sugden AL, Sagnella GA, MacGregor GA. Prolonged decrease in blood pressure after atrial peptide infusion in essential hypertension: a new anti-pressor mechanism? Clin Sci 1989; 77: 253-258.
  • Singer DRJ, Markandu ND, Miller MA, Sugden A Louise, MacGregor GA. Potassium channel stimulation in normal subjects and in patients with essential hypertension: an acute study with Chromokalin (BRL 34915). J Hypertens 1989; 7(suppl 6): S294-S295.
  • Cappuccio FP, Strazzullo P, Barba G, Lacone R, Buckley MG, Sugden AL, Miller MA, Sagnella GA, MacGregor GA, Mancini M. Atrial natriuretic peptide and tubular sodium handling during normal daily life in man. J Hypertens 1989; 7(supp 6): S228-S229.